Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dicer ribonuclease III (commonly called Dicer or DICER1) is a multidomain, magnesium-dependent endoribonuclease belonging to the RNase III family. Structurally, it contains a helicase domain, DUF283, a PAZ domain, a connector helix, two RNase III domains (IIIa and IIIb), and a C-terminal dsRNA-binding domain. Dicer functions as a molecular ruler, binding double-stranded RNA and cleaving these precursors into short fragments (typically 21–25 nucleotides) with a 2-nucleotide 3' overhang. This activity is central to the generation and maturation of microRNAs (miRNAs) and small interfering RNAs (siRNAs), enabling sequence-specific regulation of gene expression (RNA silencing). In humans, Dicer is encoded by the DICER1 gene, which is crucial for development, differentiation, antiviral defense, and prevents oncogenic transformation—loss or mutation can result in disease or promote cancer. Dicer is not a receptor, transporter, or channel; it is a catalytic enzyme essential for RNA processing.
For drugs or therapeutics that modulate Dicer: inhibition or enhancement of dsRNA cleavage function, affecting production of miRNA/siRNA and downstream gene silencing. RNAi therapeutics: require Dicer activity to generate active siRNA/miRNA fragments for target mRNA silencing.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dicer ribonuclease III (DICER).